ClearPoint Neuro (CLPT) Long-Term Deferred Tax (2013 - 2014)
ClearPoint Neuro's (CLPT) quarterly Long-Term Deferred Tax came in at $38989.0 in Q4 2014, down 99.84% year-on-year from $25.0 million in Q4 2013, and down 99.84% quarter-over-quarter from $25.0 million in Q4 2013.
ClearPoint Neuro (CLPT) Long-Term Deferred Tax (2013 - 2014) Analysis & Trends
ClearPoint Neuro has disclosed Long-Term Deferred Tax across 2 years of filings, most recently posting $38989.0 for Q4 2014.
- Long-Term Deferred Tax for Q4 2014 came in at $38989.0, down 99.84% year-over-year; the trailing twelve-month figure through Dec 2014 was $38989.0 (down 99.84% YoY), and the FY2014 annual result was $38989.0, down 99.84% from the prior year.
- Long-Term Deferred Tax came in at $38989.0 for Q4 2014 at ClearPoint Neuro, down from $25.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $25.0 million in Q4 2013 to a low of $38989.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 524.46 Mn | 488.86 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 38,989.00 |
| Dec 31, 2013 | 24.96 Mn |